Skip to content

Ljungström family office

Family officePublic sources — Collected from public sources, not yet cross-checked.

Ljungström family office is a family office. It joined 1 round tracked by OSH in the last 90 days.

What they look for

Activity

1
Deals, 90 days
1
Deals, 12 months
0
Led, 12 months
$75.8M
Median disclosed round

Frequent co-investors:Mission BioCapitalNovo HoldingsSound BioventuresInnovestor Life ScienceEIFO

Computed from OSH Rounds. A deal is a round the investor led or joined.

Portfolio from OSH Rounds

  • Oct 1 · Series A

    Breye Therapeutics€67.5M

    Led by Mission BioCapital, Novo Holdings · with Sound Bioventures, +6

    1 source

Questions and answers

How active is Ljungström family office?

In OSH Rounds, Ljungström family office joined 1 round in the last 90 days and 1 in the last 12 months, leading 0.

Something wrong? Suggest a correction.

Sources

  1. 1.Denmark’s Breye Therapeutics raises €67.5 million to advance oral therapies for early treatment of retinal diseases — EU-Startups, Oct 2, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026